Antigenics Inc. (
Q4 2010 Earnings Conference Call
February 17, 2011, 11:00 am ET
Garo Armen – Chairman & CEO
Ren Benjamin – Rodman
Shamma Freeman [ph]
Good morning. My name is Tracy, and I’ll be your conference operator today. At this time I would like to welcome everyone to the Fourth-Quarter and Year-Ended 2010 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. (Operator instructions) Thank you.
I would now like to introduce and turn the call over to Garo Armen, Chairman and CEO of Agenus. You may begin your conference.
Thank you, and very good morning everyone. Welcome to Agenus conference call to discuss the financial results for the quarter and year ended December 31, 2010. With me today is Shalini Sharp, Vice President and CFO. Normally, Shalini does the financial part of the call, but she has partially lost her voice, so I will chip in today but she will be available for questions.
We hope that all of you have had a chance to review the press release that was issued this morning. During this call we will review our financial results as well as provide a corporate update. We will then open it up to question and answers.
Before we continue, I would like to remind you that this conference call will contain certain forward-looking statements including, without limitation, statements regarding the company’s cash position, timing of potential income streams and development and commercialization efforts, timelines, availability of data and potential efficacy with respect to product and product candidates of the company and/or its licensees and partners.